4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-016874
Chief Executive Officer sold 36,766 shares at $19.17 ($704,657)
- Chief Executive Officer acquired 36,766 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazumdar Claire Chief Executive Officer | 2026-03-09 | Option exercise 10b5-1 | +36,766 | $3.79 | $139,336 | 376,158 | D |
| Mazumdar Claire Chief Executive Officer | 2026-03-09 | Sale 10b5-1 | −36,766 | $19.17 | $704,657 | 339,392 | D |
| Derivatives | |||||||
| Mazumdar Claire Chief Executive Officer | 2026-03-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −36,766 | 191,107 | D | ||
| Open-market sales · 36,766 sh · avg $19.17 · $704,657 | |||||||
Loading xslF345X05/wk-form4_1773262035.xml…